Immunology is closely attributed to Immune dysregulation in his work. His research brings together the fields of Immunology and Immune dysregulation. Borrowing concepts from Cancer research, he weaves in ideas under Genetics. He performs integrative study on Cancer research and Genetics. Benjamin L. Ebert integrates many fields, such as Gene and Immune system, in his works. He integrates many fields in his works, including Immune system and Myeloid. He integrates Myeloid and Haematopoiesis in his studies. Benjamin L. Ebert integrates Haematopoiesis with Myelopoiesis in his research. His study in Stem cell extends to Myelopoiesis with its themes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Aravind Subramanian;Pablo Tamayo;Vamsi K. Mootha;Sayan Mukherjee.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem;Ophir Shalem;Neville E Sanjana;Neville E Sanjana;Ella Hartenian;Xi-Shun Shi.
MicroRNA expression profiles classify human cancers
Jun Lu;Gad Getz;Eric A. Miska;Eric A. Miska;Ezequiel Alvarez-Saavedra.
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori.
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei.
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert.
Cancer Cell (2005)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal;Pierre Fontanillas;Jason Flannick;Jason Flannick;Alisa Manning.
The New England Journal of Medicine (2014)
Clinical effect of point mutations in myelodysplastic syndromes.
Rafael Bejar;Kristen Stevenson;Omar Abdel-Wahab;Naomi Galili.
The New England Journal of Medicine (2011)
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Yana Pikman;Benjamin H Lee;Thomas Mercher;Elizabeth McDowell.
PLOS Medicine (2006)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma;Rafael Bejar;Siddhartha Jaiswal;R. Coleman Lindsley.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: